Renewal of Provisional Consent to the Distribution of a New Medicine Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto: Schedule Trade Name: Avonex. Active Ingredient(s): Interferon beta-1a 30 g. Dosage Form: Injection with diluent. NZ Sponsor: CSL (New Zealand) Limited. Manufacturer(s): Aquitaine Pharm International, Pierre Fabre Medicament Subsidiary, Idron, France and Ben Venue Laboratories Inc, Bedford, Ohio, United States of America. Note: This consent is valid for 2 years from the 30th day of October 1999. Dated this 1st day of July 1999. G. R. BOYD, Chief Advisor, Regulation and Safety (pursuant to delegation given by the Minister of Health on the 20th day of February 1997).